Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)

Systemic gene replacement therapy for treatment of X-linked myotubular myopathy (XLMTM)

US Patent 9839677 · Granted Dec 12, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2024
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2024
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2024
Selective gene therapy expression system2023
Drug discovery platform for Duchenne cardiomyopathy2023
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2023
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2023
Systemic gene replacement therapy for treatment of X-linked myotubular myopathy 2023
Antisense targeting dynamin 2 and use for the treatment of centronuclear myopath2022
Compositions and methods for the treatment of myotonic dystrophy2022
Compositions and methods for the treatment of nucleotide repeat expansion disord2021
Treatment for myopathy2021